Filing Details
- Accession Number:
- 0001610618-23-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-13 21:21:56
- Reporting Period:
- 2023-03-13
- Accepted Time:
- 2023-03-13 21:21:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1610618 | Cidara Therapeutics Inc. | CDTX | Biological Products, (No Disgnostic Substances) (2836) | 461537286 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1638380 | Shane Ward | 6310 Nancy Ridge Drive Suite 101 San Diego CA 92121 | Coo & Clo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-13 | 4,329 | $1.53 | 84,576 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- Includes 8,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP") on May 20, 2022 and November 18, 2022.
Billionaire Hedge Funds
